Supply. (a) The Parties shall endeavor in good faith to execute within [***] days after the Closing a supply agreement, in form and substance reasonably satisfactory to the Parties and with pricing and commercial terms reflecting the terms customarily pertaining to Seller’s arms’ length agreements for the supply of similar products, for the clinical products that Novartis elects to supply, and that Buyer elects to purchase from Novartis.
Appears in 9 contracts
Samples: Bct197 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bct197 Asset Purchase Agreement (Mereo Biopharma Group PLC), Bps804 Asset Purchase Agreement (Mereo Biopharma Group PLC)